IP Library Assignment 061494/0444
Patent Assignment
Reel/Frame 061494/0444

Merger

Recorded: 2022-10-21 Pages: 5
Assignor
COMET THERAPEUTICS, INC.
Executed: 2022-07-07
Assignee
VECTIVBIO COMET AG
AESCHENVORSTADT 36, BASEL, 4051, SWITZERLAND
Covered Property (1)
Stable Pantetheine Derivatives for the Treatment of Pantothenate Kinase Associated Neurodegeneration (Pkan) and Methods for the Synthesis of Such Compounds
Patent: 9,963,472 →
Application: 15/034,244 →
Publication: US 2016/0297840
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 24, 2017
From: ACIES BIO D.O.O.
To: TM3 THERAPEUTICS B.V.
Reel/Frame 044583/0321 →
Change of Name Jan 27, 2020
From: TM3 THERAPEUTICS B.V.
To: COMET THERAPEUTICS B.V.
Reel/Frame 051624/0646 →
Assignment of Assignor's Interest Jan 27, 2020
From: COMET THERAPEUTICS B.V.
To: COMET THERAPEUTICS, INC.
Reel/Frame 051624/0654 →
Security Interest Mar 29, 2022
From: COMET THERAPEUTICS, INC.
To: KREOS CAPITAL VI (UK) LIMITED
Reel/Frame 059420/0866 →
Release of Security Interest Aug 24, 2023
From: KREOS CAPITAL VI (UK) LIMITED
To: VECTIVBIO COMET AG, F/K/A COMET THERAPEUTICS, INC.
Reel/Frame 064702/0362 →